Report Detail

Request for Sample of this report

Service & Software Global Oncology CRO Services Market 2025 by Company, Regions, Type and Application, Forecast to 2031

  • RnM4649489
    • |
  • 18 November, 2025
    • |
  • Global
    • |
  • 126 Pages
    • |
  • GIR
    • |
  • Service & Software

According to our latest research, the global Oncology CRO Services market size will reach USD 1196 million in 2031, growing at a CAGR of 5.2% over the analysis period.
Oncology CRO (Contract Research Organization) services refer to the specialized range of research and support services provided by external organizations to pharmaceutical companies, biotechnology firms, and other entities involved in oncology drug development and research. These CROs possess in-depth expertise in the complex field of oncology, encompassing knowledge of cancer biology, various types of malignancies, and the latest advancements in oncology research. Their services typically include all stages of clinical trial management, from the initial design and planning of oncology trials, which involves formulating study protocols, defining endpoints, and selecting appropriate patient populations. They handle patient recruitment and enrollment, ensuring that participants meet the strict eligibility criteria for the trials. Oncology CROs also conduct data management and analysis, collecting, organizing, and interpreting the vast amounts of data generated during the trials to assess the safety and efficacy of new cancer treatments. Additionally, they may offer regulatory affairs support, helping clients navigate the complex and ever-evolving landscape of oncology drug approvals by regulatory authorities. These services are crucial in accelerating the development of innovative oncology therapies, as they allow companies to leverage the specialized skills and resources of CROs, ultimately leading to the discovery and approval of new drugs that can improve the lives of cancer patients.

This report is a detailed and comprehensive analysis for global Oncology CRO Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Oncology CRO Services market size and forecasts, in consumption value ($ Million), 2020-2031
Global Oncology CRO Services market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Oncology CRO Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Oncology CRO Services market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oncology CRO Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oncology CRO Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Catalyst, Celerion, Parexel, Crown Bioscience, Novotech, Charles River Laboratories, Medelis, ProPharma, TD2 Oncology, Precision, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Oncology CRO Services market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Preclinical Oncology CRO Services
Clinical Trial Management
Others
Market segment by Application
Pharmaceutical Companies
Academic and Research Institutions
Others
Market segment by players, this report covers
Catalyst
Celerion
Parexel
Crown Bioscience
Novotech
Charles River Laboratories
Medelis
ProPharma
TD2 Oncology
Precision
Emerald Clinical
Worldwide Clinical Trials
Champions Oncology
Medpace
Allucent
Atlantic Research Group
Explicyte
InnoSer
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Oncology CRO Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oncology CRO Services, with revenue, gross margin, and global market share of Oncology CRO Services from 2020 to 2025.
Chapter 3, the Oncology CRO Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Oncology CRO Services market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oncology CRO Services.
Chapter 13, to describe Oncology CRO Services research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Oncology CRO Services by Type
    • 1.3.1 Overview: Global Oncology CRO Services Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global Oncology CRO Services Consumption Value Market Share by Type in 2024
    • 1.3.3 Preclinical Oncology CRO Services
    • 1.3.4 Clinical Trial Management
    • 1.3.5 Others
  • 1.4 Global Oncology CRO Services Market by Application
    • 1.4.1 Overview: Global Oncology CRO Services Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Pharmaceutical Companies
    • 1.4.3 Academic and Research Institutions
    • 1.4.4 Others
  • 1.5 Global Oncology CRO Services Market Size & Forecast
  • 1.6 Global Oncology CRO Services Market Size and Forecast by Region
    • 1.6.1 Global Oncology CRO Services Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global Oncology CRO Services Market Size by Region, (2020-2031)
    • 1.6.3 North America Oncology CRO Services Market Size and Prospect (2020-2031)
    • 1.6.4 Europe Oncology CRO Services Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific Oncology CRO Services Market Size and Prospect (2020-2031)
    • 1.6.6 South America Oncology CRO Services Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa Oncology CRO Services Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 Catalyst
    • 2.1.1 Catalyst Details
    • 2.1.2 Catalyst Major Business
    • 2.1.3 Catalyst Oncology CRO Services Product and Solutions
    • 2.1.4 Catalyst Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Catalyst Recent Developments and Future Plans
  • 2.2 Celerion
    • 2.2.1 Celerion Details
    • 2.2.2 Celerion Major Business
    • 2.2.3 Celerion Oncology CRO Services Product and Solutions
    • 2.2.4 Celerion Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Celerion Recent Developments and Future Plans
  • 2.3 Parexel
    • 2.3.1 Parexel Details
    • 2.3.2 Parexel Major Business
    • 2.3.3 Parexel Oncology CRO Services Product and Solutions
    • 2.3.4 Parexel Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Parexel Recent Developments and Future Plans
  • 2.4 Crown Bioscience
    • 2.4.1 Crown Bioscience Details
    • 2.4.2 Crown Bioscience Major Business
    • 2.4.3 Crown Bioscience Oncology CRO Services Product and Solutions
    • 2.4.4 Crown Bioscience Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Crown Bioscience Recent Developments and Future Plans
  • 2.5 Novotech
    • 2.5.1 Novotech Details
    • 2.5.2 Novotech Major Business
    • 2.5.3 Novotech Oncology CRO Services Product and Solutions
    • 2.5.4 Novotech Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Novotech Recent Developments and Future Plans
  • 2.6 Charles River Laboratories
    • 2.6.1 Charles River Laboratories Details
    • 2.6.2 Charles River Laboratories Major Business
    • 2.6.3 Charles River Laboratories Oncology CRO Services Product and Solutions
    • 2.6.4 Charles River Laboratories Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Charles River Laboratories Recent Developments and Future Plans
  • 2.7 Medelis
    • 2.7.1 Medelis Details
    • 2.7.2 Medelis Major Business
    • 2.7.3 Medelis Oncology CRO Services Product and Solutions
    • 2.7.4 Medelis Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Medelis Recent Developments and Future Plans
  • 2.8 ProPharma
    • 2.8.1 ProPharma Details
    • 2.8.2 ProPharma Major Business
    • 2.8.3 ProPharma Oncology CRO Services Product and Solutions
    • 2.8.4 ProPharma Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 ProPharma Recent Developments and Future Plans
  • 2.9 TD2 Oncology
    • 2.9.1 TD2 Oncology Details
    • 2.9.2 TD2 Oncology Major Business
    • 2.9.3 TD2 Oncology Oncology CRO Services Product and Solutions
    • 2.9.4 TD2 Oncology Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 TD2 Oncology Recent Developments and Future Plans
  • 2.10 Precision
    • 2.10.1 Precision Details
    • 2.10.2 Precision Major Business
    • 2.10.3 Precision Oncology CRO Services Product and Solutions
    • 2.10.4 Precision Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Precision Recent Developments and Future Plans
  • 2.11 Emerald Clinical
    • 2.11.1 Emerald Clinical Details
    • 2.11.2 Emerald Clinical Major Business
    • 2.11.3 Emerald Clinical Oncology CRO Services Product and Solutions
    • 2.11.4 Emerald Clinical Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Emerald Clinical Recent Developments and Future Plans
  • 2.12 Worldwide Clinical Trials
    • 2.12.1 Worldwide Clinical Trials Details
    • 2.12.2 Worldwide Clinical Trials Major Business
    • 2.12.3 Worldwide Clinical Trials Oncology CRO Services Product and Solutions
    • 2.12.4 Worldwide Clinical Trials Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Worldwide Clinical Trials Recent Developments and Future Plans
  • 2.13 Champions Oncology
    • 2.13.1 Champions Oncology Details
    • 2.13.2 Champions Oncology Major Business
    • 2.13.3 Champions Oncology Oncology CRO Services Product and Solutions
    • 2.13.4 Champions Oncology Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Champions Oncology Recent Developments and Future Plans
  • 2.14 Medpace
    • 2.14.1 Medpace Details
    • 2.14.2 Medpace Major Business
    • 2.14.3 Medpace Oncology CRO Services Product and Solutions
    • 2.14.4 Medpace Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Medpace Recent Developments and Future Plans
  • 2.15 Allucent
    • 2.15.1 Allucent Details
    • 2.15.2 Allucent Major Business
    • 2.15.3 Allucent Oncology CRO Services Product and Solutions
    • 2.15.4 Allucent Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Allucent Recent Developments and Future Plans
  • 2.16 Atlantic Research Group
    • 2.16.1 Atlantic Research Group Details
    • 2.16.2 Atlantic Research Group Major Business
    • 2.16.3 Atlantic Research Group Oncology CRO Services Product and Solutions
    • 2.16.4 Atlantic Research Group Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 Atlantic Research Group Recent Developments and Future Plans
  • 2.17 Explicyte
    • 2.17.1 Explicyte Details
    • 2.17.2 Explicyte Major Business
    • 2.17.3 Explicyte Oncology CRO Services Product and Solutions
    • 2.17.4 Explicyte Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
    • 2.17.5 Explicyte Recent Developments and Future Plans
  • 2.18 InnoSer
    • 2.18.1 InnoSer Details
    • 2.18.2 InnoSer Major Business
    • 2.18.3 InnoSer Oncology CRO Services Product and Solutions
    • 2.18.4 InnoSer Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
    • 2.18.5 InnoSer Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Oncology CRO Services Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of Oncology CRO Services by Company Revenue
    • 3.2.2 Top 3 Oncology CRO Services Players Market Share in 2024
    • 3.2.3 Top 6 Oncology CRO Services Players Market Share in 2024
  • 3.3 Oncology CRO Services Market: Overall Company Footprint Analysis
    • 3.3.1 Oncology CRO Services Market: Region Footprint
    • 3.3.2 Oncology CRO Services Market: Company Product Type Footprint
    • 3.3.3 Oncology CRO Services Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Oncology CRO Services Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global Oncology CRO Services Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global Oncology CRO Services Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global Oncology CRO Services Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America Oncology CRO Services Consumption Value by Type (2020-2031)
  • 6.2 North America Oncology CRO Services Market Size by Application (2020-2031)
  • 6.3 North America Oncology CRO Services Market Size by Country
    • 6.3.1 North America Oncology CRO Services Consumption Value by Country (2020-2031)
    • 6.3.2 United States Oncology CRO Services Market Size and Forecast (2020-2031)
    • 6.3.3 Canada Oncology CRO Services Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico Oncology CRO Services Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe Oncology CRO Services Consumption Value by Type (2020-2031)
  • 7.2 Europe Oncology CRO Services Consumption Value by Application (2020-2031)
  • 7.3 Europe Oncology CRO Services Market Size by Country
    • 7.3.1 Europe Oncology CRO Services Consumption Value by Country (2020-2031)
    • 7.3.2 Germany Oncology CRO Services Market Size and Forecast (2020-2031)
    • 7.3.3 France Oncology CRO Services Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom Oncology CRO Services Market Size and Forecast (2020-2031)
    • 7.3.5 Russia Oncology CRO Services Market Size and Forecast (2020-2031)
    • 7.3.6 Italy Oncology CRO Services Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific Oncology CRO Services Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific Oncology CRO Services Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific Oncology CRO Services Market Size by Region
    • 8.3.1 Asia-Pacific Oncology CRO Services Consumption Value by Region (2020-2031)
    • 8.3.2 China Oncology CRO Services Market Size and Forecast (2020-2031)
    • 8.3.3 Japan Oncology CRO Services Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea Oncology CRO Services Market Size and Forecast (2020-2031)
    • 8.3.5 India Oncology CRO Services Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia Oncology CRO Services Market Size and Forecast (2020-2031)
    • 8.3.7 Australia Oncology CRO Services Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America Oncology CRO Services Consumption Value by Type (2020-2031)
  • 9.2 South America Oncology CRO Services Consumption Value by Application (2020-2031)
  • 9.3 South America Oncology CRO Services Market Size by Country
    • 9.3.1 South America Oncology CRO Services Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil Oncology CRO Services Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina Oncology CRO Services Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa Oncology CRO Services Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa Oncology CRO Services Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa Oncology CRO Services Market Size by Country
    • 10.3.1 Middle East & Africa Oncology CRO Services Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey Oncology CRO Services Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia Oncology CRO Services Market Size and Forecast (2020-2031)
    • 10.3.4 UAE Oncology CRO Services Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 Oncology CRO Services Market Drivers
  • 11.2 Oncology CRO Services Market Restraints
  • 11.3 Oncology CRO Services Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Oncology CRO Services Industry Chain
  • 12.2 Oncology CRO Services Upstream Analysis
  • 12.3 Oncology CRO Services Midstream Analysis
  • 12.4 Oncology CRO Services Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Oncology CRO Services. Industry analysis & Market Report on Oncology CRO Services is a syndicated market report, published as Global Oncology CRO Services Market 2025 by Company, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Oncology CRO Services market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo